, Tracking Stock Market Picks
Enter Symbol:
Alkermes, Inc. (ALKS) [hlAlert]

up 47.29 %

Alkermes, Inc. (ALKS) downgraded to Hold by Roth Capital

Posted on: Friday,  Apr 3, 2009  9:25 AM ET by Roth Capital

Roth Capital rated Hold Alkermes, Inc. (NASDAQ: ALKS) on 04/03/2009. Previously Roth Capital rated Buy Alkermes, Inc. (NASDAQ: ALKS) on 11/13/2008.,
when the stock price was $7.21. Since then, Alkermes, Inc. has gained 47.30% as of 04/03/2009's recent price of $10.62.
If you would have followed the previous Roth Capital's recommendation on ALKS, you would have gained 47.29% of your investment in 141 days.

Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/3/2009 9:25 AM Hold
as of 12/31/2009
1 Week   
1 Month   
3 Months   
1 YTD down  -0.28 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/13/2008 10:25 AM Buy
7.21 14.00
9/17/2008 8:25 AM Buy
12.67 16.00
8/19/2008 9:25 AM Hold
14.58 17.00
8/11/2008 10:25 AM Hold
16.60 18.00
8/1/2008 8:25 AM Hold
14.87 17.00
4/22/2008 8:25 AM Buy
11.29 15.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy